Global Novel Cell Sorting and Separation Market Size By Type (Cancer Cell, Immune Cells), By Application (Cell Research, Biomedical Diagnosis), By Region, And Segment Forecasts, 2023 to 2032

The Global Novel Cell Sorting and Separation Market was valued at USD 3.1 billion in 2023 and is projected to surpass USD 7.9 billion by 2031, growing at a CAGR of 12.6% during the forecast period from 2023 to 2031. The market is expanding rapidly due to rising research activities in cell therapy, personalized medicine, and oncology. The increasing need for precise isolation of rare cells, improvements in single-cell technologies, and the growing adoption of microfluidics and AI-assisted platforms in biomedical research are boosting demand. Furthermore, advancements in cell-based diagnostics and regenerative medicine are propelling the adoption of high-throughput and high-purity cell sorting systems globally.

Drivers:

Increasing Demand for Precision Medicine:

Precision medicine requires high-fidelity isolation of specific cell types, driving the adoption of novel cell sorting and separation technologies that offer speed, accuracy, and reproducibility.

Surge in Stem Cell and Cancer Research:

Rapid advancements in stem cell therapy and cancer diagnostics are elevating the demand for sophisticated cell separation platforms that can isolate stem cells and circulating tumor cells (CTCs) with high purity.

Technological Innovations:

Microfluidic-based and label-free sorting methods, integration of AI and machine learning in cell identification, and advancements in fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) are significantly contributing to market expansion.

Restraints:

High Equipment and Operational Costs:

Advanced sorting technologies involve significant capital investment and operational costs, limiting their adoption across small-scale research labs and emerging economies.

Technical Complexity:

Operating and maintaining high-end sorting equipment requires specialized knowledge and training, posing a challenge for labs with limited technical expertise.

Opportunity:

Expanding Applications in Immunotherapy and Regenerative Medicine:

Cell sorting is critical in immunotherapy (e.g., CAR-T cell development) and regenerative medicine, presenting immense growth potential as these domains gain prominence.

Growth in Emerging Markets:

Increasing investments in life sciences infrastructure in countries like China, India, and Brazil are opening lucrative opportunities for market players, especially in clinical research and biopharma applications.

Market by System Type Insights:

The Microfluidics-Based Cell Sorting segment dominated in 2023, owing to its low reagent usage, compact design, and suitability for point-of-care diagnostics. However, the Fluorescence-Activated Cell Sorting (FACS) segment is expected to witness the fastest growth due to its high throughput and multi-parametric analysis capabilities, especially in cancer and immunology research.

Market by End-use Insights:

Research Laboratories and Academic Institutes accounted for the largest market share in 2023. The surge in genomic and proteomic studies, alongside growing government grants for academic research, contributes to this dominance. Meanwhile, the Biopharmaceutical and Biotechnology Companies segment is poised for substantial growth driven by rising investments in cell-based drug discovery and therapeutic development.

Market by Regional Insights:

North America led the market in 2023, supported by robust R&D infrastructure, advanced healthcare systems, and a strong presence of leading biotechnology firms. Asia-Pacific is expected to register the fastest CAGR during the forecast period, driven by increasing healthcare investments, expanding biopharma sectors, and government support for life science innovation in countries like China, India, and South Korea.

Competitive Scenario:

Leading players in the Global Novel Cell Sorting and Separation Market include Becton, Dickinson and Company, Miltenyi Biotec, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Sony Biotechnology Inc., Beckman Coulter Life Sciences, Akadeum Life Sciences, and Cytonome/ST, LLC. These companies are focusing on strategic collaborations, technological advancements, and geographic expansion to strengthen their global footprint.

In 2023, Miltenyi Biotec launched a next-gen magnetic cell sorter with AI-driven sorting algorithms for higher yield and purity.

Thermo Fisher Scientific expanded its Flow Cytometry platform with cloud-enabled analytics for real-time cell analysis in 2024.

Sony Biotechnology partnered with academic research institutions in 2025 to advance AI-based single-cell sorting technology.

Scope of Work – Global Novel Cell Sorting and Separation Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 7.9 billion

CAGR (2023–2031) 12.6%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising precision medicine demand, stem cell & cancer research expansion, and microfluidic technology advancements

Opportunities Immunotherapy and regenerative medicine applications, emerging market growth

Key Market Developments:

2023: Miltenyi Biotec introduced SmartSort AI™, an AI-integrated magnetic cell sorter enhancing throughput by 25%.

2024: Bio-Rad acquired a start-up specializing in microfluidic chip-based sorting to diversify it